Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL-Reference-Cited by-同舟云学术

Development of Polypeptide-based Nanoparticles for Non-viral Delivery of CD22 RNA Trans-splicing Molecule as a New Precision Medicine Candidate Against B-lineage ALL

Published:2015-07 Issue:7 Volume:2 Page:649-659
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Uckun Fatih M.,Mitchell Lloyd G.,Qazi Sanjive,Liu Yang,Zheng Nan,Myers Dorothea E.,Song Ziyuan,Ma Hong,Cheng Jianjun

Funder

DHHS

National Cancer Institute

V-Foundation

Nautica Triathlon

Ronald McDonald House Charities of Southern California

NSF-CHE

NIH

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference25 articles.

1. Differential effects of selective inhibitors targeting the PI3K/AKT/mTOR pathway in acute lymphoblastic leukemia;Badura;PLoS One,2013

2. Reactive and bioactive cationic α-helical polypeptide template for nonviral gene delivery;Gabrielson;Angew. Chem. Int. Ed.,2012

3. Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12months of the completion of primary therapy: Children's Oncology Group Study CCG-1941;Gaynon;J. Clin. Oncol.,2006

4. Trans-splicing repair of mutant p53 suppresses the growth of hepatocellular carcinoma cells in vitro and in vivo;He;Sci. Rep.,2015

5. Integrated genomic analysis of relapsed childhood acute lymphoblastic leukemia reveals therapeutic strategies;Hogan;Blood,2011

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RNA exon editing: Splicing the way to treat human diseases;Molecular Therapy - Nucleic Acids;2024-09

2. Role of Nano and Biopharmaceutics in Precision Medicine;Recent Progress in Pharmaceutical Nanobiotechnology: A Medical Perspective;2023-12-27

3. CD22 Exon 12 Deletion as an Independent Predictor of Poor Treatment Outcomes in B-ALL;Cancers;2023-03-04

4. Nanotechnology-based diagnostics and therapeutics in acute lymphoblastic leukemia: a systematic review of preclinical studies;Nanoscale Advances;2023

5. ERBB1/EGFR and JAK3 Tyrosine Kinases as Potential Therapeutic Targets in High-Risk Multiple Myeloma;Onco;2022-10-14